Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 168-172 , December 2009

The role of the local microenvironment in regulating susceptibility and immune responses to sexually transmitted viruses in the female genital tract

  • Charu Kaushic

      Affiliations

    • Corresponding Author InformationTel.: +1 905 525 9140x22988; fax: +1 905 522 6750.

Received 27 January 2009 ,Revised 22 July 2009 ,Accepted 1 August 2009.

References 

  1. Andersen JM, Al-Khairy D, Ingalls RR. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol. Reprod. 2006;74:824–831
  2. Ashkar AA, Bauer S, Mitchell WJ, Vieira J, Rosenthal KL. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 2003;77:8948–8956
  3. Asin SN, Fanger MW, Wildt-Perinic D, Ware PL, Wira CR, Howell AL. Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J. Infect. Dis. 2004;190:236–245
  4. Bhavanam S, Snider DP, Kaushic C. Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone. Vaccine. 2008;26:6165–6172
  5. Bobardt MD, Chatterji U, Selvarajah S, Van Der Schueren B, David G, Kahn B, et al. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J. Virol. 2007;81:395–405
  6. Bouschbacher M, Bomsel M, Verronese E, Gofflo S, Ganor Y, Dezutter-Dambuyant C, et al. Early events in HIV transmission through a human reconstructed vaginal mucosa. Aids. 2008;22:1257–1266
  7. Brabin L. Interactions of female hormonal environment, susceptibility to viral infection and disease progression. AIDS Patient Care STDS. 2002;16:211–221
  8. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006;12:1365–1371
  9. Center for Disease Control and Prevention, C., 2009. Trends in Reportable sexually transmitted diseases in the United States, 2007. Available at: http://www.cdc.gov/std/stats07.
  10. Coombs RW, Reichelderfer PS, Landay AL. Recent observations on HIV type-1 infection in the genital tract of men and women. Aids. 2003;17:455–480
  11. Corey L, Wald A. Genital Herpes. In:  Holmes KK,  Sparling PF,  Mardh PA,  Lemon SM,  Stamm WE,  Piot P,  Wasserheit JN editor. Sexually Transmitted Diseases. third ed.. New York: McGraw-Hill; 1999;
  12. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of Toll-like Receptor 4-mediated signaling. J. Immunol. 2002;168:2424–2432
  13. Fox-Canale AM, Hope TJ, Martinson J, Lurain JR, Rademaker AW, Bremer JW, et al. Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology. 2007;369:55–68
  14. Geijtenbeek TB, Kwon DS, Torensma R, Al E. DC-SIGN, a dendritic cell-specific HIV-1 binding protein that enhances trans-infection of T-cells. Cell. 2000;100:587–597
  15. Gillgrass AE, Ashkar AA, Rosenthal KL, Kaushic C. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 2003;77:9845–9851
  16. Gillgrass AE, Fernandez SA, Rosenthal KL, Kaushic C. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation. J. Virol. 2005;79:3107–3116
  17. Gillgrass AE, Tang VA, Towarnicki KM, Rosenthal KL, Kaushic C. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue. J. Virol. 2005;79:3117–3126
  18. Herbst-Kralovetz MM, Pyles RB. Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection. J. Virol. 2006;80:9988–9997
  19. Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, Eschenbach D, et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity. 2007;26:257–270
  20. Kaushic C, Murdin AD, Underdown BJ, Wira CR. Chlamydia trachomatis infection in the female reproductive tract of rat: influence of progesterone on infectivity and immune response. Infect. Immun. 1998;66:893–898
  21. Kaushic C, Zhou F, Murdin AD, Wira CR. Effect of estradiol and progesterone on susceptibility and immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 2000;68:4207–4216
  22. Kaushic C, Ashkar AA, Reid LA, Rosenthal KL. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J. Virol. 2003;77:4558–4565
  23. Lavreys L, Baeten JM, Martin HL, Overbaugh J, Mandaliya K, Ndinya-Achola J, et al. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. Aids. 2004;18:695–697
  24. Looker KJ, Garnett GP, Schmid GP. An estimate of global prevalence and incidence of herpes simplex virus type 2 infection. Bull. World Health Organ. 2008;86:737–816
  25. Macdonald EM, Savoy A, Gillgrass A, Fernandez S, Smieja M, Rosenthal KL, et al. Susceptibility of human female primary genital epithelial cells to herpes simplex virus, type-2 and the effect of TLR3 ligand and sex hormones on infection. Biol. Reprod. 2007;77:1049–1059
  26. Maher D, Wu X, Schacker T, Horbul J, Southern P. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc. Natl. Acad. Sci. U.S.A. 2005;102:11504–11509
  27. Maher DM, Zhang ZQ, Schacker TW, Southern PJ. Ex vivo modeling of oral HIV transmission in human palatine tonsil. J. Histochem. Cytochem. 2005;53:631–642
  28. Medzhitov R, Janeway CA. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 1997;91:295–298
  29. Miller CJ, Shattock RJ. Target cells in vaginal HIV transmission. Microbes Infect. 2003;5:59–67
  30. Miller L, Patton DL, Meier A, Thwin SS, Hooton TM, Eschenbach DA. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet. Gynecol. 2000;96:431–439
  31. Moss GB, Clemetson D, D’costa L, Plummer FA, Ndinya-Achola JO, Reilly M, et al Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. J. Infect. Dis. 1991;164:588–591
  32. Mostad SB, Kreiss JK, Ryncarz AJ, Mandaliya K, Chohan B, Ndinya-Achola J, et al. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J. Infect. Dis. 2000;181:58–63
  33. Nazli A, Yao XD, Smieja M, Rosenthal KL, Ashkar AA, Kaushic C. Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women. Antiviral Res. 2009;81:103–112
  34. Parr MB, Parr EL. Vaginal immunity in the HSV-2 mouse model. Int. Rev. Immunol. 2003;22:43–63
  35. Paz-Bailey G, Ramaswamy M, Hawkes SJ, Geretti AM. Herpes simplex virus type 2: epidemiology and management options in developing countries. Sex Trans. Infect. 2007;83:16–22
  36. Philips DM, Bourinbaiar AS. Mechanism of HIV spread from lymphocytes to epithelia. Virology. 1992;186:261–273
  37. Prakash M, Kapembwa MS, Gotch F, Patterson S. Oral contraceptive use induces upregulation of CCR5 chemokine receptor in the cervical epithelium of healthy women. J. Reprod. Immunol. 2002;54:117–131
  38. Pudney J, Quayle AJ, Anderson DJ. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 2005;73:1253–1263
  39. Quayle AJ. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J. Reprod. Immunol. 2002;57:61–79
  40. Quinn TC, Wawer MJ, Sewankambo N, Al E. Viral load and heterosexual transmission of HIV-1. Rakai project Study Group. N. Engl. J. Med. 2000;342:921–929
  41. Schaefer TM, Fahey JV, Wright JA, Wira CR. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J. Immunol. 2005;174:992–1002
  42. Stoddard E, Cannon G, Ni H, Kariko K, Capodici J, Malamud D, et al. gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. J. Immunol. 2007;179:3126–3132
  43. Tengvall S, Josefsson A, Holmgren J, Harandi AM. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice. J. Reprod. Immunol. 2005;68:53–69
  44. Turville SG, Cameron PU, Handley A, Lin G, Pohlmann S, Doms RW, et al. Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 2002;3:975–983
  45. Unaids, 2008. UNAIDS Report on AIDS Epidemic, July 2008.
  46. Wang CC, Mcclelland RS, Overbaugh J, Reilly M, Panteleeff DD, Mandaliya K, et al. The effect of hormonal contraception on genital tract shedding of HIV-1. Aids. 2004;18:205–209
  47. Wira CR, Kaushic C, Richardson J. Role of sex hormones and cytokines in regulating mucosal immune system in the female reproductive tract. In:  Ogra PL,  Mestecky J,  Lamm ME,  Strober W,  Bienenstock J,  McGhee JR editor. Mucosal Immunity. second ed.. San Diego: Academic Press; 1999;
  48. Wira CR, Grant-Tschudy KS, Crane-Godreau MA. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am. J. Reprod. Immunol. 2005;53:65–76

PII: S0165-0378(09)00472-0

doi: 10.1016/j.jri.2009.08.010

Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 168-172 , December 2009

Article Tools